In high-grade invasive bladder cancer and acute myeloid leukemia, the protein level of CPT1B in cancer tissues is lower than that of adjacent cancer and can promote the malignant biological behavior of cancer cells and prolong the survival of patients [96,97]. This evidence concerns the gene CPT1B and acute myeloid leukemia.